XLS — Xlife Sciences AG Balance Sheet
0.000.00%
- CH₣120.54m
- CH₣268.05m
- CH₣0.83m
- 38
- 56
- 45
- 40
Annual balance sheet for Xlife Sciences AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.7 | 1.96 | 0.221 | 0.219 | 0.099 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.297 | 0.484 | 0.957 | 17.9 | 14 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.02 | 2.47 | 1.25 | 18.1 | 14.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.433 | 0.67 | 0.536 | 0.394 | 0.269 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 186 | 480 | 490 | 512 | 540 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.13 | 2.33 | 1.93 | 5.83 | 9.26 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 55.5 | 269 | 255 | 244 | 235 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 130 | 211 | 235 | 268 | 305 |
| Total Liabilities & Shareholders' Equity | 186 | 480 | 490 | 512 | 540 |
| Total Common Shares Outstanding |